|
Vast Therapeutics Announces Results Showing Ability to Eradicate Anthrax
BIOC51 Antimicrobial Activity against Bacillus anthracis (Anthrax), Adding to the List of Bacteria Susceptible to the Company’s Drug Candidate |
RSS Feed
|
AddressContact Us
|
|
Copyright © 2022 Vast Therapeutics - All Rights Reserved
|